Radioiodine (¹³¹I) is the treatment of choice for most hyperthyroid cats, with a cure rate exceeding 95%, no requirement for general anesthesia, and the ability to treat ectopic thyroid tissue that neither surgery nor medical management can reliably address.Journal of Vete…+2
The primary decision framework is reversible-first when renal function is uncertain. Because 15–50% of hyperthyroid cats have concurrent chronic kidney disease (CKD) that is masked by the hyperthyroid-driven increase in glomerular filtration rate, the standard recommendation is to stabilize with a reversible treatment before committing to an irreversible one.AAHA Clinical G…+1 Methimazole serves this role: it allows renal function to unmask over weeks before a permanent decision is made. Cats that develop azotemia after ¹³¹I-induced euthyroidism have a median survival of 2.8 years versus 4.3 years in those that remain nonazotemic — a 1.5-year difference — making pre-treatment renal assessment clinically consequential.Journal of the…
Methimazole is the standard reversible option and the most commonly used treatment overall. The 2023 AAHA guidelines recommend starting at 1.25–2.5 mg PO q24h for the first week, then titrating to 2.5–5 mg PO q12–24h, targeting a total thyroxine (T4) concentration of 1.0–2.5 mcg/dL.AAHA Clinical G… Methimazole does not affect the growth of the adenomatous tissue, so doses require upward adjustment over time and the disease remains progressive.Journal of the…+1 Adverse effects — including vomiting, facial pruritus, hepatotoxicity, and bone marrow dyscrasias (severe leukopenia, anemia, thrombocytopenia) — can appear up to several months after initiation and are not reliably dose-related; all non-gastrointestinal adverse effects require discontinuation and a change in treatment strategy.AAHA Clinical G… Transdermal methimazole mitigates gastrointestinal side effects but does not prevent the other adverse effects.AAHA Clinical G… Median survival on methimazole alone is approximately 2 years, compared to 5.3 years for cats treated with methimazole followed by ¹³¹I.Journal of the…
Radioiodine is the preferred definitive treatment once the cat is a confirmed candidate. It achieves euthyroidism in >95% of cats, treats all abnormal thyroid tissue including ectopic foci, and does not require anesthesia.Journal of Vete…+2 With individualized low-dose protocols, overt iatrogenic hypothyroidism occurs in fewer than 5% of treated cats, though approximately 20% develop mild subclinical hypothyroidism.Journal of Vete… Persistent hyperthyroidism after ¹³¹I occurs in 5–10% of cats and requires retreatment or alternative therapy.Journal of Vete… Before ¹³¹I, thyroid-stimulating hormone (TSH) should be measured and treatment postponed if TSH is detectable (≥0.03 ng/mL), as a detectable TSH indicates residual normal thyroid tissue that will concentrate iodine and substantially increases the risk of iatrogenic hypothyroidism — the odds ratio for overt hypothyroidism in cats with detectable TSH is 12.1, versus 3.0 for subclinical hypothyroidism.Journal of Vete…+1 Methimazole should be discontinued at least 1 week before ¹³¹I to allow TSH suppression to re-establish; with this approach, TSH remains suppressed in 98% of hyperthyroid cats.Journal of Vete…
Thyroidectomy is a curative option when ¹³¹I is unavailable, but carries specific procedural risks. It requires general anesthesia in a cat that may have thyrotoxic cardiomyopathy, and parathyroid damage is a recognized risk even in experienced hands.AAHA Clinical G… Ectopic thyroid tissue — present in 3.9–23% of cats — will not be addressed surgically and can cause recurrence.Journal of Vete… Long-term remission rates after thyroidectomy are lower than after ¹³¹I: one study reported 19–47% of cats in long-term remission after unilateral or bilateral thyroidectomy versus 100% after ¹³¹I.Veterinary Evid… Medical stabilization before surgery is required.AAHA Clinical G… Thyroidectomy does offer the advantage of histopathology, which is relevant when thyroid carcinoma is suspected — a consideration in cats that fail ¹³¹I, where carcinoma was confirmed in 5 of 10 surgically treated cats in one series.Journal of Vete…
An iodine-restricted diet is a non-curative alternative for cats in whom all other options are unsuitable. It requires strict exclusion of all other food sources, including food from other pets and outdoor hunting, and some cats fail to normalize T4 even after prolonged exclusive feeding.AAHA Clinical G… Feeding the iodine-restricted diet to nonhyperthyroid cats in the same household is not harmful.AAHA Clinical G…
| Treatment | Protocol | Efficacy | Key Caveat |
|---|---|---|---|
| Methimazole | 1.25–2.5 mg PO q24h week 1; then 2.5–5 mg PO q12–24h; target T4 1.0–2.5 mcg/dL | Controls but not curative; MST ~2 years alone | Progressive disease requires dose escalation; non-GI adverse effects require discontinuation |
| Radioiodine (¹³¹I) | Individualized dose; discontinue methimazole ≥1 week prior; check TSH, postpone if ≥0.03 ng/mL | >95% cure rate; MST 5.3 years (after methimazole bridge) | 12% develop post-treatment azotemia (MST 2.8 yr); 5–10% treatment failure |
| Thyroidectomy | Medically stabilize first; requires general anesthesia | 19–47% long-term remission | Parathyroid risk; misses ectopic tissue (3.9–23% of cats); carcinoma histopathology advantage |
| Iodine-restricted diet | Exclusive feeding required; no other food sources | Non-curative; some cats fail to normalize T4 | Strict dietary compliance essential; not suitable as sole long-term strategy in most cats |
Would you like guidance on how to interpret post-treatment T4 and TSH values to distinguish euthyroidism, subclinical hypothyroidism, and overt hypothyroidism after ¹³¹I?